0.4685
Rani Therapeutics Holdings Inc stock is traded at $0.4685, with a volume of 576.07K.
It is up +2.25% in the last 24 hours and down -6.22% over the past month.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
See More
Previous Close:
$0.4582
Open:
$0.454
24h Volume:
576.07K
Relative Volume:
0.33
Market Cap:
$22.06M
Revenue:
$1.20M
Net Income/Loss:
$-52.41M
P/E Ratio:
-0.5148
EPS:
-0.91
Net Cash Flow:
$-31.25M
1W Performance:
-7.34%
1M Performance:
-6.22%
6M Performance:
-60.63%
1Y Performance:
-76.81%
Rani Therapeutics Holdings Inc Stock (RANI) Company Profile
Name
Rani Therapeutics Holdings Inc
Sector
Industry
Phone
(408) 457-3700
Address
2051 RINGWOOD AVENUE, SAN JOSE
Compare RANI with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
RANI
Rani Therapeutics Holdings Inc
|
0.4685 | 21.95M | 1.20M | -52.41M | -31.25M | -0.91 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Aug-02-24 | Initiated | Oppenheimer | Outperform |
Jun-14-24 | Initiated | Maxim Group | Buy |
Jun-13-24 | Initiated | Rodman & Renshaw | Buy |
Apr-17-23 | Resumed | BTIG Research | Buy |
Oct-11-22 | Initiated | UBS | Buy |
Jul-27-22 | Initiated | H.C. Wainwright | Buy |
Jun-13-22 | Initiated | Wedbush | Outperform |
View All
Rani Therapeutics Holdings Inc Stock (RANI) Latest News
Short interest data insights for Rani Therapeutics Holdings Inc.Gap Up & Free Technical Confirmation Trade Alerts - newser.com
Long term hold vs stop loss in Rani Therapeutics Holdings Inc.2025 Price Targets & Entry Point Confirmation Alerts - newser.com
How to manage a losing position in Rani Therapeutics Holdings Inc.Trade Performance Summary & Growth Focused Stock Pick Reports - newser.com
Technical analysis overview for Rani Therapeutics Holdings Inc. stock2025 Market Sentiment & Free High Accuracy Swing Entry Alerts - newser.com
Is Rani Therapeutics Holdings Inc. stock a buy for dividend growthWeekly Investment Summary & Risk Adjusted Buy/Sell Alerts - newser.com
Multi asset correlation models including Rani Therapeutics Holdings Inc.Insider Buying & Verified Entry Point Detection - newser.com
Custom watchlist performance reports with Rani Therapeutics Holdings Inc.Stop Loss & Weekly Sector Rotation Insights - newser.com
Tools to assess Rani Therapeutics Holdings Inc.’s risk profileWeekly Gains Report & Weekly Market Pulse Alerts - newser.com
Is Rani Therapeutics Holdings Inc. forming a reversal patternShare Buyback & Consistent Growth Equity Picks - newser.com
Published on: 2025-10-09 03:36:21 - newser.com
Candlestick signals on Rani Therapeutics Holdings Inc. stock todayGold Moves & Detailed Earnings Play Alerts - newser.com
Price momentum metrics for Rani Therapeutics Holdings Inc. explainedShare Buyback & Daily Volume Surge Trade Alerts - newser.com
What drives Rani Therapeutics Holdings Inc stock priceMarket Rumors and News & Exceptional Profit Growth Tips - earlytimes.in
What analysts say about Rani Therapeutics Holdings Inc stockUtilities Sector Analysis & Access Powerful Market Insights - earlytimes.in
Is Rani Therapeutics Holdings Inc. stock affected by interest rate hikesJuly 2025 Analyst Calls & High Yield Equity Trading Tips - newser.com
Why Rani Therapeutics Holdings Inc. stock could outperform in 2025July 2025 Recap & Weekly Market Pulse Alerts - newser.com
Price action breakdown for Rani Therapeutics Holdings Inc.July 2025 Retail & Safe Swing Trade Setups - newser.com
Building trade automation scripts for Rani Therapeutics Holdings Inc.Earnings Summary Report & Daily Momentum Trading Reports - newser.com
Rani Therapeutics Holdings Inc Stock (RANI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Rani Therapeutics Holdings Inc Stock (RANI) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Imran Talat | Chief Executive Officer |
Dec 09 '24 |
Buy |
1.94 |
10,296 |
19,974 |
494,751 |
South Cone Investments Limited | 10% Owner |
Oct 15 '24 |
Sale |
2.65 |
3,829,360 |
10,141,674 |
8,302,194 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):